2017
Ventricular arrhythmias immediately following transcatheter pulmonary valve implantation: A cause for concern?
Simmons MA, Elder RW, Shabanova V, Hellenbrand W, Asnes J. Ventricular arrhythmias immediately following transcatheter pulmonary valve implantation: A cause for concern? Catheterization And Cardiovascular Interventions 2017, 91: 920-926. PMID: 29280541, DOI: 10.1002/ccd.27454.Peer-Reviewed Original ResearchConceptsTranscatheter pulmonary valve implantationRight ventricular outflow tractNative outflow tractsSignificant ventricular arrhythmiasPulmonary valve implantationVentricular arrhythmiasOutflow tractValve implantationAnti-arrhythmic medicationsBeta-blocker therapySingle-center studyVentricular outflow tractLong-term therapySudden cardiac deathCare of patientsChange of doseHemodynamic instabilityHemodynamic compromiseCardiac deathMedian ageMedical therapyPediatric patientsSignificant arrhythmiasCenter studyTerm therapyPercutaneous transcatheter pulmonary valve replacement in children weighing less than 20 kg
Martin MH, Shahanavaz S, Peng LF, Asnes JD, Riley M, Hellenbrand WE, Balzer DT, Gray RG, McElhinney DB. Percutaneous transcatheter pulmonary valve replacement in children weighing less than 20 kg. Catheterization And Cardiovascular Interventions 2017, 91: 485-494. PMID: 29193671, DOI: 10.1002/ccd.27432.Peer-Reviewed Original ResearchMeSH KeywordsAge FactorsBody WeightCardiac CatheterizationChildChild DevelopmentChild, PreschoolCoronary AngiographyEchocardiography, DopplerFemaleHeart Valve ProsthesisHeart Valve Prosthesis ImplantationHumansMalePostoperative ComplicationsPulmonary ValveRetrospective StudiesRisk FactorsTreatment OutcomeUnited StatesConceptsTranscatheter pulmonary valve replacementPercutaneous transcatheter pulmonary valve replacementPulmonary valve replacementTetralogy of FallotValve replacementVein accessInternal jugular vein accessExcellent valve functionMean Doppler gradientMild pulmonary regurgitationIliac vein injuryCases of endocarditisFemoral vein accessSuccessful valve implantationJugular vein accessIJV accessRVOT reinterventionMelody valveAdverse eventsDoppler gradientPulmonary regurgitationValve implantationMedian ageVein injuryRoot compressionOutcomes of Transcatheter Tricuspid Valve-in-Valve Implantation in Patients With Ebstein Anomaly
Taggart NW, Cabalka AK, Eicken A, Aboulhosn JA, Thomson JDR, Whisenant B, Bocks ML, Schubert S, Jones TK, Asnes JD, Fagan TE, Meadows J, Hoyer M, Martin MH, Ing FF, Turner DR, Latib A, Tzifa A, Windecker S, Goldstein BH, Delaney JW, Kuo JA, Foerster S, Gillespie M, Butera G, Shahanavaz S, Horlick E, Boudjemline Y, Dvir D, McElhinney DB, Registry V. Outcomes of Transcatheter Tricuspid Valve-in-Valve Implantation in Patients With Ebstein Anomaly. The American Journal Of Cardiology 2017, 121: 262-268. PMID: 29153244, DOI: 10.1016/j.amjcard.2017.10.017.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedBioprosthesisCardiac CatheterizationEbstein AnomalyEndocarditisFemaleHeart Valve ProsthesisHeart Valve Prosthesis ImplantationHumansMaleMiddle AgedPostoperative ComplicationsProsthesis FailureRegistriesReoperationThrombosisTreatment OutcomeTricuspid ValveTricuspid Valve InsufficiencyYoung AdultConceptsEbstein's anomalyValve dysfunctionValve implantationTricuspid valveAcute valve thrombosisMedium-term durabilityPatient underwent reinterventionPatient-prosthesis mismatchSevere tricuspid regurgitationTranscatheter Tricuspid ValveNYHA statusProcedural mortalityTranscatheter tricuspidUnderwent reinterventionMelody valveValve thrombosisMost patientsTricuspid regurgitationCommon indicationAcute resultsSurgical bioprosthesesInternational registryInvasive alternativePatientsTVIV
2016
Transcatheter valve implantation for right atrium‐to‐right ventricle conduit obstruction or regurgitation after modified Björk–fontan procedure
Shah AH, Horlick EM, Eicken A, Asnes JD, Bocks ML, Boudjemline Y, Cabalka AK, Fagan TE, Schubert S, Mahadevan VS, Dvir D, Osten M, McElhinney DB. Transcatheter valve implantation for right atrium‐to‐right ventricle conduit obstruction or regurgitation after modified Björk–fontan procedure. Catheterization And Cardiovascular Interventions 2016, 89: 298-305. PMID: 27465501, DOI: 10.1002/ccd.26648.Peer-Reviewed Original ResearchMeSH KeywordsAdultBioprosthesisBlood Vessel ProsthesisBlood Vessel Prosthesis ImplantationCanadaCardiac CatheterizationEuropeFemaleFontan ProcedureGraft Occlusion, VascularHeart Defects, CongenitalHeart Valve DiseasesHeart Valve ProsthesisHeart Valve Prosthesis ImplantationHemodynamicsHumansMaleMiddle AgedNorth AmericaProsthesis DesignProsthesis FailureRecovery of FunctionRegistriesRetrospective StudiesStentsTime FactorsTreatment OutcomeConceptsRight ventricleBjörk modificationFontan procedureValve implantationExtra-anatomic graftRetrospective multicenter registrySapien valve implantationLow procedural riskTranscatheter valve implantationRight atrial appendageCardiovascular causesPercutaneous transcatheterRA-RVUncomplicated implantationMulticenter registrySAPIEN 3Clinical improvementValve dysfunctionConduit dysfunctionFontan circulationPulmonary circulationAtrial appendageFontan pathwayTranscatheter implantationProcedural riskTranscatheter Tricuspid Valve-in-Valve Implantation for the Treatment of Dysfunctional Surgical Bioprosthetic Valves
McElhinney DB, Cabalka AK, Aboulhosn JA, Eicken A, Boudjemline Y, Schubert S, Himbert D, Asnes JD, Salizzoni S, Bocks ML, Cheatham JP, Momenah TS, Kim DW, Schranz D, Meadows J, Thomson JD, Goldstein BH, Crittendon I, Fagan TE, Webb JG, Horlick E, Delaney JW, Jones TK, Shahanavaz S, Moretti C, Hainstock MR, Kenny DP, Berger F, Rihal CS, Dvir D. Transcatheter Tricuspid Valve-in-Valve Implantation for the Treatment of Dysfunctional Surgical Bioprosthetic Valves. Circulation 2016, 133: 1582-1593. PMID: 26994123, DOI: 10.1161/circulationaha.115.019353.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overBioprosthesisCardiac CatheterizationChildChild, PreschoolFemaleFollow-Up StudiesHeart Valve Prosthesis ImplantationHumansInternationalityLength of StayMaleMiddle AgedProsthesis FailureRegistriesTreatment OutcomeTricuspid Valve InsufficiencyYoung AdultConceptsNew York Heart Association class IIIClass IIITV dysfunctionValve implantationNew York Heart Association class IValve sizePulmonary valve prosthesisTricuspid regurgitation gradePatient-related factorsSurgical bioprosthetic valvesTranscatheter Tricuspid ValveTV reinterventionsMulticenter registrySAPIEN valveMedian ageRegurgitation gradeSerious complicationsClinical statusTricuspid valveLabel useTranscatheter prosthesesBioprosthetic valvesValve prosthesisPatientsValve bioprostheses